Arformoterol/Budesonide

· Korea United Pharm. Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Arformoterol/Budesonide, covering 2021-09-24 to 2021-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Arformoterol/Budesonide for COVID-19 [Phase 2]